These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34002058)

  • 1. Clinical trial strategies for rare neurodevelopmental disorders: challenges and opportunities.
    Krishnan ML; Berry-Kravis E; Capal JK; Carpenter R; Gringras P; Hipp JF; Miller MT; Mingorance A; Philpot BD; Pletcher MT; Rotenberg A; Tjeertes J; Wang PP; Willgoss T; de Wit MC; Jeste SS
    Nat Rev Drug Discov; 2021 Sep; 20(9):653-654. PubMed ID: 34002058
    [No Abstract]   [Full Text] [Related]  

  • 2. The promise and challenges of rare cancer research.
    Komatsubara KM; Carvajal RD
    Lancet Oncol; 2016 Feb; 17(2):136-138. PubMed ID: 26868336
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical research in rare diseases: new challenges, opportunities and ethical issues].
    Alfonso Farnós I; Alcalde Bezhold G
    An Pediatr (Engl Ed); 2020 Oct; 93(4):219-221. PubMed ID: 32921623
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapeutic Advances in Autism and Other Neurodevelopmental Disorders.
    Neul JL; Sahin M
    Neurotherapeutics; 2015 Jul; 12(3):519-20. PubMed ID: 26076992
    [No Abstract]   [Full Text] [Related]  

  • 5. A network of patients with orphan retinal diseases for clinical trials: goals, structure, challenges.
    Weleber RG
    Retina; 2005 Dec; 25(8 Suppl):S66-S67. PubMed ID: 16374344
    [No Abstract]   [Full Text] [Related]  

  • 6. Methodology of clinical trials for rare diseases.
    Tudur Smith C; Williamson PR; Beresford MW
    Best Pract Res Clin Rheumatol; 2014 Apr; 28(2):247-62. PubMed ID: 24974061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trial design for rare cancers: why a less conventional route may be required.
    Panageas KS
    Expert Rev Clin Pharmacol; 2015; 8(6):661-3. PubMed ID: 26517109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical trial methodology in rare gynecologic tumor research: Strategies for success.
    Brown J; Naumann RW; Brady WE; Coleman RL; Moore KN; Gershenson DM
    Gynecol Oncol; 2018 Jun; 149(3):605-611. PubMed ID: 29699802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The stakes of pre- and post-market authorization development and clinical assessment].
    Schwebig A
    Presse Med; 2012 May; 41 Suppl 1():S6-8. PubMed ID: 22483770
    [No Abstract]   [Full Text] [Related]  

  • 10. Rare-disease project has global ambitions.
    Abbott A
    Nature; 2011 Apr; 472(7341):17. PubMed ID: 21475168
    [No Abstract]   [Full Text] [Related]  

  • 11. Evidence-based medicine for rare diseases: implications for data interpretation and clinical trial design.
    Behera M; Kumar A; Soares HP; Sokol L; Djulbegovic B
    Cancer Control; 2007 Apr; 14(2):160-6. PubMed ID: 17387301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic disorders and neurobehavioural phenotypes.
    Huijbregts S; Jansen A
    J Intellect Disabil Res; 2017 Sep; 61(9):819-822. PubMed ID: 28833840
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical trials In BMT: ensuring that rare diseases and rarer therapies are well done.
    Shurin S; Krischer J; Groft SC
    Biol Blood Marrow Transplant; 2012 Jan; 18(1 Suppl):S8-11. PubMed ID: 22226117
    [No Abstract]   [Full Text] [Related]  

  • 14. In search of a cure: PACS1 Research Foundation as a model of rare disease therapy development.
    Rylaarsdam L; Reddy T; Guemez-Gamboa A
    Trends Genet; 2022 Feb; 38(2):109-112. PubMed ID: 34836651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy for rare diseases: summary of a National Institutes of Health workshop, September 13, 2012.
    O'Reilly M; Kohn DB; Bartlett J; Benson J; Brooks PJ; Byrne BJ; Camozzi C; Cornetta K; Crystal RG; Fong Y; Gargiulo L; Gopal-Srivastava R; High KA; Jacobson SG; Jambou RC; Montgomery M; Rosenthal E; Samulski RJ; Skarlatos SI; Sorrentino B; Wilson JM; Xie Y; Corrigan-Curay J
    Hum Gene Ther; 2013 Apr; 24(4):355-62. PubMed ID: 23517518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A revealing flaw.
    Leslie M
    Science; 2021 Feb; 371(6530):663-665. PubMed ID: 33574194
    [No Abstract]   [Full Text] [Related]  

  • 17. Challenges associated with clinical trials for inherited and orphan retinal diseases.
    Fishman GA
    Retina; 2005 Dec; 25(8 Suppl):S10-S12. PubMed ID: 16374308
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatable inherited rare movement disorders.
    Jinnah HA; Albanese A; Bhatia KP; Cardoso F; Da Prat G; de Koning TJ; Espay AJ; Fung V; Garcia-Ruiz PJ; Gershanik O; Jankovic J; Kaji R; Kotschet K; Marras C; Miyasaki JM; Morgante F; Munchau A; Pal PK; Rodriguez Oroz MC; Rodríguez-Violante M; Schöls L; Stamelou M; Tijssen M; Uribe Roca C; de la Cerda A; Gatto EM;
    Mov Disord; 2018 Jan; 33(1):21-35. PubMed ID: 28861905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rare Gynecologic Tumors: Coming of Age.
    Gershenson DM; Okamoto A; Ray-Coquard I
    Gynecol Oncol; 2020 Apr; 157(1):1-2. PubMed ID: 32241340
    [No Abstract]   [Full Text] [Related]  

  • 20. Common genetic variants contribute to risk of rare severe neurodevelopmental disorders.
    Niemi MEK; Martin HC; Rice DL; Gallone G; Gordon S; Kelemen M; McAloney K; McRae J; Radford EJ; Yu S; Gecz J; Martin NG; Wright CF; Fitzpatrick DR; Firth HV; Hurles ME; Barrett JC
    Nature; 2018 Oct; 562(7726):268-271. PubMed ID: 30258228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.